Sun’s Specialty Gambit Paying Off, Tildrakizumab Nears Sales Milestone

About 9,000 US physicians have prescribed Winlevi

sales surge
Sun's Specialty Business Sees Uptick • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business